Catalyst Pharmaceuticals Inc (CPRX) R&D Expenses & History | Stock Alarm

Demo Sign up Log In

Catalyst Pharmaceuticals Inc · R&D Expenses

CPRX R&D Expenses

Latest reported$11.48Mperiod endingMar 31, 2026

CPRX R&D Expenses ($137.68K → $11.48M)

Annual R&D Expenses

High-resolution chart · PNG

CPRX r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Catalyst Pharmaceuticals Inc R&D Expenses — Annual fiscal periods (USD)
Period ending	R&D Expenses (USD)
Dec 31, 2025	12,709,000
Dec 31, 2024	12,648,000
Dec 31, 2023	93,150,000
Dec 31, 2022	19,789,000
Dec 31, 2021	16,936,000
Dec 31, 2020	16,497,000
Dec 31, 2019	18,843,000
Dec 31, 2018	19,919,204
Dec 31, 2017	11,375,237
Dec 31, 2016	11,369,941
Dec 31, 2015	11,801,342
Dec 31, 2014	10,117,774
Dec 31, 2013	8,096,774
Dec 31, 2012	2,659,597
Dec 31, 2011	3,383,965
Dec 31, 2010	2,306,781
Dec 31, 2009	5,097,440
Dec 31, 2008	8,710,441
Dec 31, 2007	2,990,659
Dec 31, 2006	989,144
Dec 31, 2005	1,462,889
Dec 31, 2004	378,254
Dec 31, 2003	0
Dec 31, 2002	137,680

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.